Exploring patients’ and carers’ views about the clinical use of ketamine to inform policy and practical decisions: mixed-methods study
BJPsych Open July 29, 2019 Sagar Jilka, Claire A. Murray, Ania M. Wieczorek et al. 20 citations
Patients and carers want better evidence on the long-term safety of ketamine for major depression and feel that monitoring is required, though they worry about misuse of that information. Practical barriers such as repeated travel to clinics and lack of sufficiently informed medical staff are key concerns. The study used 44 participants in 21 focus groups and an online survey, generating ten themes including monitoring, information, side-effects, recreational use, effectiveness, cost, stigma, and therapy.